Skip to content

Clinical trials

Expanded access trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Expanded access Country / region: Australia Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20062
20121

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available16
Approved for marketing11
Available4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Pfizer4
Eli Lilly and Company3
Boehringer Ingelheim2
Nuvalent Inc.2
Astellas Pharma Global Development, Inc.1
AstraZeneca1
Bayer1
BioMarin Pharmaceutical1
Eisai Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung5
Breast Neoplasms3
Carcinoma, Renal Cell3
Arthritis1
Arthritis, Rheumatoid1
COVID-191
Carcinoma, Medullary1
Colonic Neoplasms1
Colorectal Neoplasms1
Dermatitis, Atopic1

Trials

Showing 76 to 31 of 31. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.